0001437749-19-018032.txt : 20190906
0001437749-19-018032.hdr.sgml : 20190906
20190906210111
ACCESSION NUMBER: 0001437749-19-018032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190904
FILED AS OF DATE: 20190906
DATE AS OF CHANGE: 20190906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DE GREEF RODERICK
CENTRAL INDEX KEY: 0001241181
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 191080705
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC
CENTRAL INDEX KEY: 0000834365
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 943076866
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4254011400
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLIFE SOLUTION INC
DATE OF NAME CHANGE: 20030113
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
rdgdoc.xml
FORM 4
X0306
4
2019-09-04
0000834365
BIOLIFE SOLUTIONS INC
BLFS
0001241181
DE GREEF RODERICK
C/O BIOLIFE SOLUTIONS, INC.
3303 MONTE VILLA PARKWAY, SUITE 310
BOTHELL
WA
98021
1
Chief Financial Officer
Common Stock
2019-09-04
4
M
0
10000
1.64
A
35859
D
Common Stock
2019-09-04
4
S
0
10000
19.46
D
25859
D
Common Stock
2019-09-05
4
M
0
10000
1.64
A
35859
D
Common Stock
2019-09-05
4
S
0
10000
19.99
D
25859
D
Common Stock
2019-09-06
4
M
0
10000
1.64
A
35859
D
Common Stock
2019-09-06
4
S
0
10000
19.88
D
25859
D
Employee Stock Option
1.64
2019-09-04
4
M
0
10000
0
D
2019-03-01
2021-12-20
Common Stock
10000
66919
D
Employee Stock Option
1.64
2019-09-05
4
M
0
10000
0
D
2019-03-01
2021-12-20
Common Stock
10000
56919
D
Employee Stock Option
1.8099
2026-05-03
Common Stock
104000
104000
D
Employee Stock Option
1.7600
2026-03-04
Common Stock
100000
100000
D
Employee Stock Option
1.64
2019-09-06
4
M
0
10000
0
D
2019-03-01
2021-12-20
Common Stock
10000
46919
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.82 to $20.42 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.85 to $20.17 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.46 to $20.10 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The stock option vests 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.
The stock option vests 25% on the first anniversary of the grant date and thereafter, in 36 equal monthly installments. Such options shall continue to vest regardless of whether Mr. de Greef's service with the Company continues
/s/ Roderick de Greef
2019-09-06